{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:45:34Z","timestamp":1792885534620,"version":"4.5.0"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/aog.0000000000001058","type":"journal-article","created":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T15:37:48Z","timestamp":1441467468000},"page":"859-876","source":"Crossref","is-referenced-by-count":181,"title":["Management of Menopausal Symptoms"],"prefix":"10.1097","volume":"126","author":[{"given":"Andrew M.","family":"Kaunitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210126","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/GME.0000000000000196","article-title":"Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort.","volume":"21","author":"Freeman","year":"2014","journal-title":"Menopause"},{"key":"R3-27-20210126","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(08)60346-3","article-title":"Menopause.","volume":"371","author":"Nelson","year":"2008","journal-title":"Lancet"},{"key":"R4-27-20210126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajhb.1077","article-title":"Physiology of hot flashes.","volume":"13","author":"Freedman","year":"2001","journal-title":"Am J Hum Biol"},{"key":"R5-27-20210126","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2265.1985.tb03243.x","article-title":"Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism.","volume":"22","author":"Casper","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R6-27-20210126","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0002-9378(99)70437-0","article-title":"Reduced thermoregulatory null zone in postmenopausal women with hot flashes.","volume":"181","author":"Freedman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R7-27-20210126","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2105\/AJPH.2005.066936","article-title":". Longitudinal analysis of the association between vasomotor symptoms and raceethnicity across the menopausal transition: study of womens health across the nation.","volume":"96","author":"Gold","year":"2006","journal-title":"Am J Public Health"},{"key":"R8-27-20210126","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/GME.0000000000000099","article-title":"Menopause across cultures: clinical considerations.","volume":"21","author":"Sievert","year":"2014","journal-title":"Menopause"},{"key":"R9-27-20210126","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/gme.0b013e31819d88da","article-title":"Do Japanese American women really have fewer hot flashes than European Americans The Hilo Womens Health Study.","volume":"16","author":"Brown","year":"2009","journal-title":"Menopause"},{"key":"R10-27-20210126","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/AOG.0b013e318214f0de","article-title":"Duration of menopausal hot flushes and associated risk factors.","volume":"117","author":"Freeman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R11-27-20210126","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/GME.0000000000000295","article-title":"Perspectives on the first randomized sham-controlled trial of stellate ganglion block for hot flashes.","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"key":"R12-27-20210126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/gme.0b013e31826ce3ed","article-title":"Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial.","volume":"20","author":"Elkins","year":"2013","journal-title":"Menopause"},{"key":"R14-27-20210126","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/gme.0b013e31823cc5f7","article-title":". Effect of aerobic training on menopausal symptomsa randomized controlled trial.","volume":"19","author":"Moilanen","year":"2012","journal-title":"Menopause"},{"key":"R15-27-20210126","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/GME.0b013e31829e4089","article-title":". Efficacy of exercise for menopausal symptoms: a randomized controlled trial.","volume":"21","author":"Sternfeld","year":"2014","journal-title":"Menopause"},{"key":"R16-27-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11606-012-2202-6","article-title":". Paced respiration for vasomotor and other menopausal symptoms: a randomized, controlled trial.","volume":"28","author":"Carpenter","year":"2013","journal-title":"J Gen Intern Med"},{"key":"R17-27-20210126","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2147\/IJWH.S53652","article-title":"Effectiveness of a modified version of the applied relaxation technique in treatment of perimenopausal and postmenopausal symptoms.","volume":"5","author":"Saensak","year":"2013","journal-title":"Int J Womens Health"},{"key":"R18-27-20210126","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/gme.0b013e318204a05c","article-title":"Mindfulness training for coping with hot flashes: results of a randomized trial.","volume":"18","author":"Carmody","year":"2011","journal-title":"Menopause"},{"key":"R19-27-20210126","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-145-12-200612190-00003","article-title":"Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.","volume":"145","author":"Newton","year":"2006","journal-title":"Ann Intern Med"},{"key":"R21-27-20210126","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/GME.0b013e31829e40b8","article-title":". Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.","volume":"21","author":"Cohen","year":"2014","journal-title":"Menopause"},{"key":"R22-27-20210126","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of: the North American Menopause Society.","volume":"19","year":"2012","journal-title":"Menopause"},{"key":"R23-27-20210126","first-page":"202","article-title":"Practice Bulletin No. 141. American College of Obstetricians Gynecologists.","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R24-27-20210126","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis.","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"R25-27-20210126","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":". Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Womens Health Initiative randomized trial.","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"R26-27-20210126","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":". Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Womens Health Initiative randomized trials.","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"R27-27-20210126","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/AOG.0b013e3181bea950","article-title":"Endometrial cancer in postmenopausal women using estradiol-progestin therapy.","volume":"114","author":"Jaakkola","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R28-27-20210126","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.1980.03310130021021","article-title":"Oral medroxyprogesterone in the treatment of postmenopausal symptoms.","volume":"244","author":"Schiff","year":"1980","journal-title":"JAMA"},{"key":"R30-27-20210126","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1210\/jc.2013-1707","article-title":". Effects of bazedoxifeneconjugated estrogens on the endometrium and bone: a randomized trial.","volume":"99","author":"Pinkerton","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-27-20210126","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31828c5974","article-title":". Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.","volume":"121","author":"Pinkerton","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R32-27-20210126","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/gme.0b013e31824c8a5a","article-title":"Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.","volume":"19","author":"Kaunitz","year":"2012","journal-title":"Menopause"},{"key":"R34-27-20210126","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/13697137.2014.991302","article-title":"The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review.","volume":"18","author":"Depypere","year":"2015","journal-title":"Climacteric"},{"key":"R35-27-20210126","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.2011.1590","article-title":"Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk.","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"key":"R36-27-20210126","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","article-title":"Molecular and cellular basis of cardiovascular gender differences.","volume":"308","author":"Mendelsohn","year":"2005","journal-title":"Science"},{"key":"R37-27-20210126","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/13697130903195606","article-title":"Aging, menopause, cardiovascular disease and HRT. International Menopause Society Consensus Statement.","volume":"12","year":"2009","journal-title":"Climacteric"},{"issue":"suppl 1","key":"R38-27-20210126","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","article-title":". Postmenopausal hormone therapy: an Endocrine Society scientific statement.","volume":"95","author":"Santen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-27-20210126","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0008-6363(01)00466-7","article-title":"Estrogen replacement therapy, atherosclerosis, and vascular function.","volume":"53","author":"Mikkola","year":"2002","journal-title":"Cardiovasc Res"},{"key":"R40-27-20210126","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.amjcard.2008.01.043","article-title":". Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events.","volume":"101","author":"Bray","year":"2008","journal-title":"Am J Cardiol"},{"key":"R41-27-20210126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/gme.0b013e31826f80e0","article-title":". Coronary heart disease events in the Womens Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Womens Health Initiative randomized clinical trials.","volume":"20","author":"Wild","year":"2013","journal-title":"Menopause"},{"issue":"suppl 1","key":"R42-27-20210126","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.metabol.2012.08.015","article-title":"The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy.","volume":"62","author":"Manson","year":"2013","journal-title":"Metabolism"},{"key":"R43-27-20210126","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1373\/clinchem.2013.202556","article-title":"Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification.","volume":"60","author":"Bassuk","year":"2014","journal-title":"Clin Chem"},{"key":"R44-27-20210126","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":". Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"R45-27-20210126","first-page":"A13283","article-title":". Testing the menopausal hormone therapy timing hypothesis: the Early versus Late Intervention Trial with Estradiol.","volume":"130","author":"Hodis","year":"2014","journal-title":"Circulation"},{"key":"R46-27-20210126","doi-asserted-by":"crossref","first-page":"e8146","DOI":"10.1136\/bmj.e8146","article-title":"Study had insufficient power to investigate safety.","volume":"345","author":"Rossouw","year":"2012","journal-title":"BMJ"},{"key":"R47-27-20210126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/M14-0353","article-title":". Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.","volume":"161","author":"Harman","year":"2014","journal-title":"Ann Intern Med"},{"key":"R48-27-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/GME.0000000000000373","article-title":". Algorithm and mobile app for menopausal symptom management and hormonalnon-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society.","volume":"22","author":"Manson","year":"2014","journal-title":"Menopause"},{"issue":"suppl 2","key":"R49-27-20210126","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":". 2013 ACCAHA guideline on the assessment of cardiovascular risk: a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines.","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"R50-27-20210126","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2105\/AJPH.2013.301295","article-title":"The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years.","volume":"103","author":"Sarrel","year":"2013","journal-title":"Am J Public Health"},{"key":"R51-27-20210126","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.","volume":"60","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"R52-27-20210126","first-page":"887","article-title":"Committee Opinion No. 556. American College of Obstetricians Gynecologists.","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R53-27-20210126","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/IJGM.S46310","article-title":"Prevention and treatment of venous thromboembolism during HRT: current perspectives.","volume":"7","author":"Rott","year":"2014","journal-title":"Int J Gen Med"},{"key":"R54-27-20210126","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/GME.0000000000000175","article-title":"Extended duration use of menopausal hormone therapy.","volume":"21","author":"Kaunitz","year":"2014","journal-title":"Menopause"},{"key":"R57-27-20210126","first-page":"1298","article-title":"What are the concerns about custom-compounded bioidentical hormone therapy M","volume":"21","author":"Pinkerton","year":"2014","journal-title":"enopause"},{"key":"R58-27-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF03190010","article-title":"Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study.","volume":"24","author":"Timmer","year":"1999","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R59-27-20210126","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/1471-0528.12598","article-title":"Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial.","volume":"121","author":"Cherry","year":"2014","journal-title":"BJOG"},{"key":"R60-27-20210126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.275.5.370","article-title":"The Postmenopausal EstrogenProgestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.","volume":"275","year":"1996","journal-title":"JAMA"},{"key":"R61-27-20210126","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.AOG.0000251518.56369.eb","article-title":". Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.","volume":"109","author":"Steiner","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R62-27-20210126","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jmig.2014.02.012","article-title":"Endometrial cancer after endometrial ablation vs medical management of abnormal uterine bleeding.","volume":"21","author":"Dood","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"R64-27-20210126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000000620","article-title":"Female sexual dysfunction: focus on low desire.","volume":"125","author":"Kingsberg","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R65-27-20210126","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/GME.0000000000000093","article-title":". Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial.","volume":"21","author":"Huang","year":"2014","journal-title":"Menopause"},{"key":"R66-27-20210126","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.6004\/jnccn.2010.0086","article-title":"Nonhormonal management of hot flashes for women on risk reduction therapy.","volume":"8","author":"Sideras","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"R67-27-20210126","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/GME.0b013e3182a66aa7","article-title":". Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"key":"R68-27-20210126","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2014.1891","article-title":". Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.","volume":"174","author":"Joffe","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R69-27-20210126","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/GME.0000000000000194","article-title":"Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.","volume":"21","author":"Walega","year":"2014","journal-title":"Menopause"},{"key":"R70-27-20210126","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0000000000000469","article-title":"Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010.","volume":"124","author":"Jewett","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R71-27-20210126","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJMoa067423","article-title":"A study of sexuality and health among older adults in the United States.","volume":"357","author":"Lindau","year":"2007","journal-title":"N Engl J Med"},{"key":"R72-27-20210126","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Womens Sexual Health and the North American Menopause Society.","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"R73-27-20210126","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.","volume":"20","year":"2013","journal-title":"Menopause"},{"key":"R74-27-20210126","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","article-title":". Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.","volume":"124","author":"Rahn","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R75-27-20210126","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/GME.0000000000000316","article-title":". Why the product labeling for low-dose vaginal estrogen should be changed.","volume":"21","author":"Manson","year":"2014","journal-title":"Menopause"},{"key":"R76-27-20210126","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/gme.0b013e31826d36ba","article-title":"Bachmann GA;, Ospemifene Study Group. One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus.","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"key":"R77-27-20210126","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/AOG.0b013e3181a66843","article-title":"Premature ovarian failure.","volume":"113","author":"Rebar","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R78-27-20210126","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2001.19.8.2357","article-title":"Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk.","volume":"19","author":"Col","year":"2001","journal-title":"J Clin Oncol"},{"key":"R79-27-20210126","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","article-title":"Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.","volume":"93","author":"OMeara","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R80-27-20210126","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":". Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.","volume":"100","author":"Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R81-27-20210126","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone therapy after breast cancer: the Stockholm randomized trial.","volume":"97","author":"von Schoultz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R82-27-20210126","first-page":"666","article-title":"Practice Bulletin No. 126. American College of Obstetricians Gynecologists.","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R83-27-20210126","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/01.AOG.0000241091.86268.6e","article-title":"Breast cancer risk in postmenopausal women using estrogen-only therapy.","volume":"108","author":"Lyytinen","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R84-27-20210126","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":". Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"R85-27-20210126","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":". Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"R86-27-20210126","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":". Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.","volume":"100","author":"Eisen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R88-27-20210126","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/gme.0b013e3181f9f7c3","article-title":"Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.","volume":"18","author":"Olie","year":"2011","journal-title":"Menopause"},{"key":"R89-27-20210126","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice. Endometriosis.","volume":"362","author":"Giudice","year":"2010","journal-title":"N Engl J Med"},{"key":"R90-27-20210126","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1701-2163(15)30487-4","article-title":". Managing menopause in English, French.","volume":"36","author":"Reid","year":"2014","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000001058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T09:07:08Z","timestamp":1653124028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201510000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001058","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}